Brief: Mendus Receives All Regulatory Approvals For Vital-CML Study In CML

Mendus AB (publ)

09/04/2026 07:08

April 9 (Reuters) - Mendus AB (publ) IMMUN.ST:

RECEIVES ALL REGULATORY APPROVALS FOR VITAL-CML STUDY IN CML

INITIAL TOPLINE DATA FROM VITAL-CML STUDY EXPECTED IN H2 2026

Source text: ID:nMFN3jmLQh

Further company coverage: IMMUN.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))